Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Haemodialysis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Ghent

Ghent, 9000, Belgium

About this study

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Chronic haemodialysis patient
Serum albumin > 3.6 g/dl

Exclusion criteria

< 18 years

Treatment and study plan

Haemodialysis with either low or high flux membranes

Procedure

Primary outcomes

Concentration of uremic components after 3 weeks of haemodialysis

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Collaborators

Nissho Nipro Europe

Registry information

Important dates

Study start: 2001
Study completion: 2002
First posted: Oct 3, 2005
Registry last updated: Dec 28, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed